Preferential blockade of CD8+ T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 4981-4986

  Nozawa, K ^a   Ohata, J ^a   Sakurai, J ^a   Hashimoto, H ^a   Miyajima, H ^a   Yagita, H ^a   Okumura, K ^a   Azuma, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIBODY; CD137 LIGAND; CD8 ANTIGEN; DOUBLE STRANDED DNA; GAMMA INTERFERON; GLYCOPROTEIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD137; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; GRAFT VERSUS HOST REACTION; LETHALITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 0035500277     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.4981     Document Type: Article

References (42)

1. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
2. Molecular and biological characterization of human 4-1BB and its ligand
3. 4-1BB T cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells
4. - T lymphocytes by 4-1BB ligand
5. Potential role of 4-1BB in T cell activation: Comparison with the costimulatory molecule CD28
6. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
7. 4-1BB is a bone fide CD8 T cell survival signal
8. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
9. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
10. + murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells
11. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BB: And CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
12. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
13. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination
14. - T cells
15. Costimulation of antigen-specific CD4 T cells by 4-1BB ligand
16. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
17. Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells
18. Graft-vs-host reactions: Clues to the etiopathology of a spectrum of immunological disease
19. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes
20. Differential cytokine expression in acute and chronic murine graft-versus-host-disease
21. T-cell interactions in autoimmunity: Insights from a murine model of graft-versus-host disease
22. Th2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity
23. Preferential activation of Th2 cells in chronic graft-versus-host reaction
24. CTLA4Ig treatment ameliorates the lethality of murine graftversus-host disease across major histocompatibility complex barriers
25. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease
26. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease
27. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD
28. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
29. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule
30. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity
31. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis
32. + T cells
33. Regulation of murine IgE production in SJA/9 and nude mice: Potentiation of IgE production by recombinant interleukin 4
34. Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses
35. + T cells
36. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease
37. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
38. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease
39. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease
40. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies
41. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
42. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy